{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T08:51:52Z","timestamp":1702889512866},"reference-count":23,"publisher":"Media Sphere Publishing Group","issue":"1. Vyp. 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. nevrol. psikhiatr. im. S.S. Korsakova"],"published-print":{"date-parts":[[2015]]},"DOI":"10.17116\/jnevro20151152243-51","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T09:32:47Z","timestamp":1460626367000},"page":"43","source":"Crossref","is-referenced-by-count":6,"title":["Treatment of endogenous depression with venflaxine: clinical action, tolerability and personalized treatment options"],"prefix":"10.17116","volume":"115","author":[{"given":"G. P.","family":"Panteleeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. V.","family":"Oleichik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. I.","family":"Abramova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. E.","family":"Yumatova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro20151152243-51-1","unstructured":"Stahl S.M. Chto bolit pri depressii? (referat). Obozr psikhiatr i medpsikhol 2000; 4: 51\u201452."},{"key":"key-10.17116\/jnevro20151152243-51-2","doi-asserted-by":"crossref","unstructured":"Thase M.E., Entsuah A.R., Rudolph R.L. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001; 178: 234\u2014241.","DOI":"10.1192\/bjp.178.3.234"},{"key":"key-10.17116\/jnevro20151152243-51-3","doi-asserted-by":"crossref","unstructured":"Vermeiden M.L., Mulder P.G., van den Broek W.W., Bruijn J.A. A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients. J Psychiatr Res 2013; 47: 10: 1337\u20141342.","DOI":"10.1016\/j.jpsychires.2013.05.029"},{"key":"key-10.17116\/jnevro20151152243-51-4","unstructured":"Mosolov S.N., Kostyukova E.G., Gorodnichev A.V., Timofeev I.V., Ladyzhenskii M.Ya., Serditov O.V. Klinicheskaya effektivnost' i perenosimost' preparata venlafaksin (velaksin) pri lechenii umerennoi i tyazheloi depressii. Trudnyi patsient 2007; 11: 72\u201478."},{"key":"key-10.17116\/jnevro20151152243-51-5","doi-asserted-by":"crossref","unstructured":"Llorca P.M., Fernandez J.L. Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation. Int J ClinPract 2007; 61: 4: 702\u2014710.","DOI":"10.1111\/j.1742-1241.2007.01335.x"},{"key":"key-10.17116\/jnevro20151152243-51-6","doi-asserted-by":"crossref","unstructured":"Perahia D.G., Pritchett Y.L., Kajdasz D.K., Bauer M., Jain R., Russell J.M., Walker D.J., Spencer K.A., Froud D.M., Raskin J., Thase M.E. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. J Psychiatr Res 2008; 42: 1: 22\u201434.","DOI":"10.1016\/j.jpsychires.2007.01.008"},{"key":"key-10.17116\/jnevro20151152243-51-7","doi-asserted-by":"crossref","unstructured":"Montgomery S.A., Baldwin D.S., Blier P., Fineberg N.A., Kasper S., Lader M. Which antidepressant have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol 2007; 22: 323\u2014329.","DOI":"10.1097\/YIC.0b013e3282eff7e0"},{"key":"key-10.17116\/jnevro20151152243-51-8","unstructured":"Il'ina N.A. Opyt primeneniya velaksina (venlafaksin) pri trevozhnykh depressiyakh. Zhurn nevrol i psikhiat 2008; 3: 24\u201428."},{"key":"key-10.17116\/jnevro20151152243-51-9","unstructured":"Medvedev V.E., Dobrovol'skii A.V. Lechenie depressii u bol'nykh serdechno-sosudistymi zabolevaniyami. Opyt primeneniya velaksina. Psikhiat i psikhofarm 2007; 9: 3: 10\u201414."},{"key":"key-10.17116\/jnevro20151152243-51-10","doi-asserted-by":"crossref","unstructured":"Burnett F.E., Dinan T.G. Venlafaxine. Pharmacology and Therapeutic Potential in the Treatment of Depression. Human Psychopharmacol 1998; 13: 153\u2014162.","DOI":"10.1002\/(SICI)1099-1077(199804)13:3<153::AID-HUP973>3.0.CO;2-S"},{"key":"key-10.17116\/jnevro20151152243-51-11","unstructured":"Drobizhev M.Yu. Chto nuzhno znat' o venlafaksine dlya ego primeneniya v klinicheskoi praktike? (Po materialam publikatsii). Psikhiat psikhofarm 2006; 8: 6: 37\u201439."},{"key":"key-10.17116\/jnevro20151152243-51-12","doi-asserted-by":"crossref","unstructured":"Nemeroff C.B., Entsuah R., Benattia I., Demitrack M., Sloan D.M., Thase M.E. Comprehensive analysis of remission with venlafaxine versus SSRI. Biol Psychiatr 2008; 63: 424\u2014434.","DOI":"10.1016\/j.biopsych.2007.06.027"},{"key":"key-10.17116\/jnevro20151152243-51-13","unstructured":"Vel'tishchev D.Yu. Effektivnost' venlafaksina (velaksin) pri lechenii depressii: rezul'taty sovremennykh issledovanii. Zhurn nevrol psikhiat 2013; 11: 79\u201481."},{"key":"key-10.17116\/jnevro20151152243-51-14","unstructured":"Yastrebov D.V. Terapevticheski rezistentnye depressii v klinike pogranichnoi psikhiatrii. Zhurn nevrol psikhiatr 2011; 111: 4: 47\u201450."},{"key":"key-10.17116\/jnevro20151152243-51-15","unstructured":"Avedisova A.S. Venlafaksin (velaksin): rezul'taty mezhdunarodnykh issledovanii antidepressanta III pokoleniya. Psikhiatr i psikhofarm 2006; 11: 2: 2\u20147."},{"key":"key-10.17116\/jnevro20151152243-51-16","doi-asserted-by":"crossref","unstructured":"Clerc G., Ruimy P., Verdeau-Pailles J. A Double-blind Comparison of Venlafaxine and Fluoxetine in Patients Hospitalized for Major Depression and melancholia. Int Clin Psychopharmacol 1994; 9: 3: 139\u2014143.","DOI":"10.1097\/00004850-199409000-00001"},{"key":"key-10.17116\/jnevro20151152243-51-17","doi-asserted-by":"crossref","unstructured":"Davidson J.R.T., Meoni P., Haudiquet V., Cantillon M., Hackett D. Achieving Remission with Venlafaxine and Fluoxetine in Major Depression: its Relationship to Anxiety Symptoms. J Depression and Andxiety 2002; 16: 4\u201413.","DOI":"10.1002\/da.10045"},{"key":"key-10.17116\/jnevro20151152243-51-18","doi-asserted-by":"crossref","unstructured":"Poirier M.F., Boyer P. Venlafaxine and Paroxetine in Treatment-Resistant Depression. Double-blind, Randomized Comparison. Brit J Psychiatry 1999; 175: 12\u201416.","DOI":"10.1192\/bjp.175.1.12"},{"key":"key-10.17116\/jnevro20151152243-51-19","doi-asserted-by":"crossref","unstructured":"Shrivastava R., Cohn C., Crowder J.,Davidson J., Dunner D., Feighner J., Kiev A., Patrick R. Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. J Clin Psychopharmacol 1994; 14: 322\u2014329.","DOI":"10.1097\/00004714-199410000-00006"},{"key":"key-10.17116\/jnevro20151152243-51-20","doi-asserted-by":"crossref","unstructured":"Smith D., Dempster C., Glanville J., Freemantle N., Anderson I. Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis. Br J Psychiatry 2002; 180: 396\u2014404.","DOI":"10.1192\/bjp.180.5.396"},{"key":"key-10.17116\/jnevro20151152243-51-21","unstructured":"Ivanov M.V., Banshchikov F.R., Kil'deev V.V. Opyt primeneniya efevelona pri lechenii trevozhno-depressivnykh rasstroistv. Psikhiatr i psikhofarm 2006; 8: 6: 24\u201427."},{"key":"key-10.17116\/jnevro20151152243-51-22","unstructured":"Nierenberg A.A. Deistvitel'no li nekotorye antidepressanty rabotayut bystree drugikh? Psikhiatr i psikhofarm 2005; 7: 6: 353\u2014356."},{"key":"key-10.17116\/jnevro20151152243-51-23","unstructured":"Smulevich A.B. Klassifikatsiya i simptomologiya depressii. Depressii v obshchei meditsine. Razdel II. M: Med inform agent 2001; 32\u201437."}],"container-title":["Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T06:58:53Z","timestamp":1498287533000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova-2\/2015\/1\/downloads\/ru\/341997-72982015018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":23,"journal-issue":{"issue":"1. Vyp. 2","published-print":{"date-parts":[[2015]]}},"alternative-id":["jnevro20151152243-51"],"URL":"https:\/\/doi.org\/10.17116\/jnevro20151152243-51","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}